Tocilizumab Treatment for Cytokine Release Syndrome in Hospitalized Patients With Coronavirus Disease 2019
Christina Price, Frederick L. Altice, Yu Shyr, Alan Koff, Lauren Pischel, George Goshua, Marwan M. Azar, Dayna McManus, Sheau‐Chiann Chen, Shana E. Gleeson, Clemente J. Britto, Veronica Azmy, Kelsey Kaman, David C. Gaston, Matthew W. Davis, Trisha Burrello, Z.M. Harris, Merceditas Villanueva, Lydia Barakat, Insoo Kang, Stuart Seropian, Geoffrey Chupp, Richard Bucala, Naftali Kaminski, Alfred Ian Lee, Patricia LoRusso, Jeffrey Topal, Charles S. Dela Cruz, Maricar Malinis
Topics & Concepts
TocilizumabMedicineCytokine release syndromeCoronavirus disease 2019 (COVID-19)CytokineSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)Coronavirus2019-20 coronavirus outbreakInterleukin 6Internal medicineDiseaseImmunologyVirologyInfectious disease (medical specialty)OutbreakCOVID-19 Clinical Research StudiesLong-Term Effects of COVID-19Kawasaki Disease and Coronary Complications